USE OF FLUORESCENT LATEX MICROSPHERES (FLMS) TO FOLLOW THE FATE OF TRANSPLANTED MYOBLASTS

被引:32
作者
SATOH, A [1 ]
HUARD, J [1 ]
LABRECQUE, C [1 ]
TREMBLAY, JP [1 ]
机构
[1] UNIV LAVAL,HOP ENFANT JESUS,NEUROBIOL LAB,1401 18E RUE,QUEBEC CITY G1J 1Z4,PQ,CANADA
关键词
FLMS (FLUORESCENT LATEX MICROSPHERES); MDX MOUSE; MYOBLAST TRANSFER THERAPY; DYSTROPHIN; DUCHENNE MUSCULAR DYSTROPHY;
D O I
10.1177/41.10.8245416
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A potential treatment for Duchenne muscular dystrophy (DMD) is injection of normal myoblasts into dystrophic muscles to induce formation of muscle fibers. To develop this therapy it is important to identify the injected myoblasts and the muscle fibers that they form in the host muscles. Fluorescent latex microspheres (FLMs) were used for this purpose in this study. Normal myoblasts were labeled with FLMs and injected into dystrophin-deficient (mdx) mice. The FLMs dearly indicated the location of injected myoblasts in the host muscle. Muscle fibers containing dystrophin were localized by immunofluorescence and immunoperoxidase. They were observed in dusters near the myoblasts labeled with FLMs. FLMs were also observed in some of these dystrophin-positive fibers in each cryostat section. These results indicate that: labeling myoblasts with FLMs can be used to trace the injected myoblasts in the muscle and to identify the muscle fibers that they formed; injected myoblasts remain near the injected site and do not migrate very far; most of the dystrophin-positive muscle fibers around the injected myoblasts result from fusion of the injected myoblasts; and the low percentage of dystrophin-positive muscle fibers is likely related to limited diffusion and lack of fusion of many injected myoblasts.
引用
收藏
页码:1579 / 1582
页数:4
相关论文
共 21 条
[1]  
Alameddine H S, 1991, Neuromuscul Disord, V1, P143, DOI 10.1016/0960-8966(91)90062-W
[2]   REGENERATION OF SKELETAL-MUSCLE FIBERS FROM AUTOLOGOUS SATELLITE CELLS MULTIPLIED INVITRO - AN EXPERIMENTAL-MODEL FOR TESTING CULTURED-CELL MYOGENICITY [J].
ALAMEDDINE, HS ;
DEHAUPAS, M ;
FARDEAU, M .
MUSCLE & NERVE, 1989, 12 (07) :544-555
[3]   INHIBITION OF MYOBLAST FUSION AFTER ONE ROUND OF DNA SYNTHESIS IN 5-BROMODEOXYURIDINE [J].
BISCHOFF, R ;
HOLTZER, H .
JOURNAL OF CELL BIOLOGY, 1970, 44 (01) :134-&
[4]   INVITRO DIFFERENTIATION OF SATELLITE CELLS ISOLATED FROM NORMAL AND DYSTROPHIC MAMMALIAN MUSCLES - A COMPARISON WITH EMBRYONIC MYOGENIC CELLS [J].
COSSU, G ;
ZANI, B ;
COLETTA, M ;
BOUCHE, M ;
PACIFICI, M ;
MOLINARO, M .
CELL DIFFERENTIATION, 1980, 9 (06) :357-368
[5]   PATHOLOGICAL RESPONSES OF RAT SKELETAL-MUSCLE TO A SINGLE SUBCUTANEOUS INJECTION OF A TOXIN ISOLATED FROM VENOM OF AUSTRALIAN TIGER SNAKE, NOTECHIS-SCUTATUS-SCUTATUS [J].
HARRIS, JB ;
JOHNSON, MA ;
KARLSSON, E .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1975, 2 (05) :383-404
[7]   DYSTROPHIN - THE PROTEIN PRODUCT OF THE DUCHENNE MUSCULAR-DYSTROPHY LOCUS [J].
HOFFMAN, EP ;
BROWN, RH ;
KUNKEL, LM .
CELL, 1987, 51 (06) :919-928
[8]   SOMATIC REVERSION SUPPRESSION OF THE MOUSE MDX PHENOTYPE INVIVO [J].
HOFFMAN, EP ;
MORGAN, JE ;
WATKINS, SC ;
PARTRIDGE, TA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1990, 99 (01) :9-25
[9]   HUMAN MYOBLAST TRANSPLANTATION - PRELIMINARY-RESULTS OF 4 CASES [J].
HUARD, J ;
BOUCHARD, JP ;
ROY, R ;
MALOUIN, F ;
DANSEREAU, G ;
LABRECQUE, C ;
ALBERT, N ;
RICHARDS, CL ;
LEMIEUX, B ;
TREMBLAY, JP .
MUSCLE & NERVE, 1992, 15 (05) :550-560
[10]   DYSTROPHIN EXPRESSION IN MYOTUBES FORMED BY THE FUSION OF NORMAL AND DYSTROPHIC MYOBLASTS [J].
HUARD, J ;
LABRECQUE, C ;
DANSEREAU, G ;
ROBITAILLE, L ;
TREMBLAY, JP .
MUSCLE & NERVE, 1991, 14 (02) :178-182